There is significant evidence showing that Wnt‐beta catenin signalling blocks immune recognition of the tumour at all stages, including tumour antigen release, antigen presentation, T‐cell priming, activation and infiltration as well as tumour cell elimination (see Figure 2; Luke et al., 2019). Here, CTNNB1 is linked to neoplasm.